New Insomnia Drug Approved by FDA

"Meyerkord and Meyerkord, LLC: A Legacy Legal Innovation"

Intermezzo, a new drug on the market for people who wake in the middle of the night and cannot fall back to sleep has been approved. The FDA originally approved the drug in 1992 at a higher dosage marketed as Ambien. Intermezzo is the same drug (zolpidem tartrate sublingual tablets) as Ambien, but a smaller dosage, 3.5 milligrams for men and 1.75 milligrams for women. The drug was approved for middle-of-the-night usage after 2 trials of 370 patients. The patients reported headaches, nausea and fatigue as the most common side effects. The FDA also warns that it should not be taken unless the person has more than 4 hours of sleep left and it should not be combined with alcohol or any other sleep aid.

Drug safety is at the forefront to our minds when it comes to treating medical conditions. The experienced Missouri product liability attorneys at Meyerkord and Meyerkord, LLC will fight for you if it is discovered that you have taken an unsafe medicine and have suffered serious side effects. Contact our knowledgeable family of attorneys at (314) 436-9958 or (800) 391-4318 if you have suffered from a loss due to the negligence of a manufacturer of consumer products such as a medicine that is later found to be unsafe.

**The choice of a lawyer is an important decision and should not be based solely upon advertisements.**

**Past results do not serve as a guarantee of future results.**

**The information on this St. Louis personal injury website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.** Intermezzo, a new drug on the market for people who wake in the middle of the night and cannot fall back to sleep has been approved. The FDA originally approved the drug in 1992 at a higher dosage marketed as Ambien. Intermezzo is the same drug (zolpidem tartrate sublingual tablets) as Ambien, but a smaller dosage, 3.5 milligrams for men and 1.75 milligrams for women. The drug was approved for middle-of-the-night usage after 2 trials of 370 patients. The patients reported headaches, nausea and fatigue as the most common side effects. The FDA also warns that it should not be taken unless the person has more than 4 hours of sleep left and it should not be combined with alcohol or any other sleep aid.